deltatrials
Completed OBSERVATIONAL NCT01237717

Relationship of Urine Sodium Excretion to Central Blood Pressure and Aortic Pulse Wave Velocity

Sponsor: DongGuk University

Conditions Hypertension
Updated 12 times since 2017 Last updated: Jan 21, 2013 Started: May 31, 2010 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Hypertension, this trial is completed. The trial is conducted by DongGuk University and has accumulated 12 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Study Description(click to expand)

Measurements: should be performed for 2 days 1. 24 hour urine Na, K and Creatinine, 24 hour urine amount 1. Calculation of urine completeness index : Cr/(21 x Bwt) 2. Definition of complete urine collection: complete index ≥ 0.7 and loss not more than one time and 100 mL 2. Peripheral blood pressure (pBP) 1. Microlife WatchBP Office 2. Sitting position 3. After 5 minutes resting 4. Peripheral systolic BP (pSBP), Peripheral diastolic BP (pDBP), 3. Central aortic blood pressure 1. SphygmoCor (AtCor Medical, Australia) 2. Central systolic blood pressure 3. Difference between peripheral SBP and central SBP (SBPp-c) 4. Pulse wave velocity 1. VP2000 (Colin, Japan) 2. Central pulse wave velocity: carotid-femoral Pulse Wave Velocity 3. Measure by tape 4. distance from suprasternal notch to carotid artery 5. distance from suprasternal notch to femoral artery 6. Silent environment 5. Blood chemistry and complete blood count 1. Measure at the morning of second day after overnight fasting 2. complete blood count, blood urea nitrogen/Creatinine, fasting blood glucose, Total cholesterol, Triglyceride, High density lipoprotein cholesterol 6. 24 hour ambulatory blood pressure measurement Measurement protocol 1. 1st day 1. Visit hospital before 9:00 AM after overnight fasting 2. start 24 hour urine...

Measurements: should be performed for 2 days

1. 24 hour urine Na, K and Creatinine, 24 hour urine amount

1. Calculation of urine completeness index : Cr/(21 x Bwt) 2. Definition of complete urine collection: complete index ≥ 0.7 and loss not more than one time and 100 mL 2. Peripheral blood pressure (pBP)

1. Microlife WatchBP Office 2. Sitting position 3. After 5 minutes resting 4. Peripheral systolic BP (pSBP), Peripheral diastolic BP (pDBP), 3. Central aortic blood pressure

1. SphygmoCor (AtCor Medical, Australia) 2. Central systolic blood pressure 3. Difference between peripheral SBP and central SBP (SBPp-c) 4. Pulse wave velocity

1. VP2000 (Colin, Japan) 2. Central pulse wave velocity: carotid-femoral Pulse Wave Velocity 3. Measure by tape 4. distance from suprasternal notch to carotid artery 5. distance from suprasternal notch to femoral artery 6. Silent environment 5. Blood chemistry and complete blood count

1. Measure at the morning of second day after overnight fasting 2. complete blood count, blood urea nitrogen/Creatinine, fasting blood glucose, Total cholesterol, Triglyceride, High density lipoprotein cholesterol 6. 24 hour ambulatory blood pressure measurement

Measurement protocol

1. 1st day

1. Visit hospital before 9:00 AM after overnight fasting 2. start 24 hour urine collection from 9:00 AM (with education for complete collection) 3. start 24 hour ambulatory blood pressure monitoring, in parallel with 24 hour urine collection 2. 2nd day

1. Measure central aortic blood pressure 2. Measure blood Lab 3. Measure Pulse Wave Velocity

Analysis of Salt sensitive gene polymorphism

1. Single Base Extension technology(SBE) 2. single nucleotide polymorphism rs2398162 and other salt sensitive hypertension related single nucleotide polymorphism

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotCompleted~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshotCompleted~Apr 2018 – ~May 2018 · 30 days · monthly snapshotCompleted~May 2018 – ~Jun 2018 · 31 days · monthly snapshotCompleted~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 7 months · monthly snapshotCompleted~Jan 2026 – present · 3 months · monthly snapshotCompleted

Change History

12 versions recorded
  1. Jan 2026 — Present [monthly]

    Completed

  2. Sep 2025 — Present [monthly]

    Completed

  3. Sep 2024 — Sep 2025 [monthly]

    Completed

  4. Jul 2024 — Sep 2024 [monthly]

    Completed

  5. Dec 2021 — Jul 2024 [monthly]

    Completed

Show 7 earlier versions
  1. Jan 2021 — Dec 2021 [monthly]

    Completed

  2. Nov 2020 — Jan 2021 [monthly]

    Completed

  3. Jun 2018 — Nov 2020 [monthly]

    Completed

  4. May 2018 — Jun 2018 [monthly]

    Completed

  5. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NANone

  6. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  7. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • DongGuk University
  • The Korean Society of Cardiology
Data source: DongGuk University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations